Research
Most of my work asks one question of different parts of the same system: what can a brain image measure that the eye can’t, and does it change what happens to the patient?
Sixteen peer-reviewed papers, fifteen abstracts, and five educational exhibits. The full list is in the CV.
- NowMemory and the aging hippocampus
- 2019 to 2023Hemorrhage and stroke on CT
- 2017 to 2021Aneurysms and flow diversion
- 2021 to nowAI in the reading room
- Where it startedRehabilitation
Memory and the aging hippocampus
LATE, limbic-predominant age-related TDP-43 encephalopathy, is common in the oldest brains and easy to mistake for Alzheimer’s disease during life. With collaborators, I’m asking whether the texture of hippocampal subfields on MRI can tell the two apart, starting with postmortem scans where the pathology is known. The interest is older than my radiology career: my first publication, in 2016, modeled inflammation relevant to Alzheimer’s disease in cultured immune cells.
Funded by the Foundation of the American Society of Neuroradiology to study radiomics of hippocampal subfields in LATE.
2025. Principal Co-InvestigatorFirst results on hippocampal subfield radiomics in LATE, followed by a postmortem MRI signature of LATE neuropathological change presented as an oral talk.
Alzheimer’s & Dementia, 2025. Alzheimer’s Imaging Consortium, AAIC, July 2026In the clinic, the same questions come up at Stanford’s Multidisciplinary Memory Conference, and in teaching: talks on imaging and radiomics of the hippocampus at USC and for Stanford’s neuroradiology fellows.
2024 to now
Hemorrhage and stroke on CT
Hematoma volume has long been the default predictor after intracerebral hemorrhage. Working with the ATACH-2 trial dataset, our group showed that the shape and texture of a bleed carry signal its size doesn’t.
Radiomic signatures from admission CT, in roughly 900 patients split into discovery and validation cohorts, tracked admission severity and three-month outcome more closely than hematoma volume did.
European Journal of Neurology, 2021Of 14 shape features, the maximum diameter in the coronal plane predicted three-month outcome better than volume. Beyond roughly 3.5 cm, outcomes were worse.
International Journal of Stroke, 2021A combined radiomic and clinical signature predicted hematoma expansion better than visual markers or the BAT score, holding up in an independent validation cohort with an AUC of 0.64.
Frontiers in Neuroscience, 2023In large hemispheric infarction, strokes extending into anterior cerebral artery territory independently predicted worse three-month outcome.
Journal of Stroke and Cerebrovascular Diseases, 2020. GAMES-RP trial MRITwo first-author pieces: a review of how imaging guides spontaneous hemorrhage care, and a case showing how contrast leaking into subdural collections after angiography can mimic a subdural hematoma on CT before clearing within about a day.
Neuroimaging Clinics of North America, 2021. Radiology Case Reports, 2019
Aneurysms and flow diversion
During medical school I worked with neurosurgical and neurointerventional teams on how flow-diverting stents heal aneurysms, how to follow them, and how to keep patients safe on antiplatelet therapy.
Across 259 aneurysms treated with the Pipeline device, occlusion accumulated from about 38% at six months to 78% at a year and 85% at two years. That curve became a proposed follow-up imaging schedule.
Journal of Neurosurgery, 2018About one in four aneurysms stayed incompletely occluded. Age over 70, size of 15 mm or more, and fusiform shape predicted it.
Journal of Neurosurgery, 2019Two flow diverters, Pipeline and FRED, performed comparably in matched internal carotid aneurysms, with 80% complete occlusion for each.
Neurosurgery, 2019On antiplatelet therapy: a pharmacy-managed protocol compared with one-time platelet testing before Pipeline placement, and a review arguing for genotype- and response-guided P2Y12 therapy.
Neurosurgery, 2019. Interventional Neuroradiology, 2021
AI in the reading room
The throughline since residency: tools that give radiologists time back and measurements they can’t make by hand, judged in real workflows rather than on benchmarks alone.
Language models that draft the impression of a radiology report, and a funded project on automated report generation. Then the human side: whether natural language tools speed dictation and ease burnout.
RSNA, 2021. Einstein Healthcare Network, 2022 to 2023, Co-Investigator. SIIM, 2023Opportunistic screening: an AI model that finds coronary artery calcium on chest CTs ordered for other reasons.
SIIM, 2023A review of AI in brain tumor imaging concluding that the promise is real, but multicenter validation and standardized image pipelines have to come first.
Seminars in Ultrasound, CT and MR, 2022Tailored language models for personalized radiology education, as an invited RSNA talk. For carotid plaque, a synthesis for WNRS: what AI adds is reach, consistency, and measurements no one can make by eye.
RSNA, Chicago, 2024. Western Neuroradiological Society, 2026: slides and takeawaysNow at Stanford: informatics work on how neuroradiology studies are hung and read, and on evaluating AI tools before clinical use. Nationally, the ASNR AI Committee and its white paper.
2025 to now
Rehabilitation
Before medicine I was a physical therapist, and some of the first questions I studied were about getting people back what a stroke or injury took.
Telerehabilitation after stroke: across 34 studies and 1,025 patients, every study reported improvement from baseline, though the methodological quality of the evidence was modest.
Telemedicine and e-Health, 2021. First presented at the American Society of Neurorehabilitation, 2018A review of neuroprotective strategies in traumatic brain injury, and why so many have failed a heterogeneous disease.
Journal of Neurosurgical Sciences, 2018
Where it’s heading
Three threads I’m pulling on now. The aging brain: imaging biomarkers that separate neurodegenerative diseases while they can still be changed. The carotid as a place for prevention: plaque and vessel wall imaging that finds risk before a stroke, not after. And AI that makes both measurable at scale, from foundation models trained on a health system’s own images to tools that fit the reading room. Underneath all three is one question: what it would take to keep a brain healthy across a whole lifetime.
If you’re working on any of this, write to me.